AstraZeneca Tagrisso gets Japanese okay for early-stage EGFR-mutated lung cancer Ruchika Sharma30 Aug 2022 9:45 AM ISTNew Delhi: AstraZeneca's Tagrisso (osimertinib) has been approved in Japan for the adjuvant treatment of patients with epidermal growth factor...
Novartis Lung cancer drug Canakinumab fails in Phase 3 trial Ruchika Sharma17 Aug 2022 4:15 PM ISTBasel: Novartis has recently announced that the Phase III CANOPY-A study evaluating adjuvant treatment with canakinumab (ACZ885), an inhibitor of...
Thermo Fisher Scientific secures USFDA nod for Oncomine Dx Target Test for lung cancers with HER2 mutations Ruchika Sharma15 Aug 2022 12:00 PM ISTThe Oncomine Dx Target Test is designed to simultaneously evaluate 23 genes associated with NSCLC.
AstraZeneca, Daiichi Sankyo get USFDA accelerated nod for Enhertu for HER2 Mutant Non-small Cell Lung Cancer Ruchika Sharma14 Aug 2022 3:30 PM ISTEnhertu is a specifically engineered HER2-directed antibody drug conjugate (ADC) being jointly developed and commercialised by AstraZeneca and Daiichi...
Merck seeks USFDA nod for Keytruda to treat non-small cell lung cancer Ruchika Sharma14 Jun 2022 12:00 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Sanofi to transfer 100 percent rights of Libtayo to Regeneron Ruchika Sharma3 Jun 2022 12:34 PM ISTUpon closing of the transaction, Regeneron will make an upfront payment of $900 million to Sanofi, which will be entitled to receive an 11% royalty on...
Eli Lilly Kinsale gets CDSCO panel nod to import, market anticancer drug Selpercatinib Dr. Divya Colin20 May 2022 5:52 PM ISTNew Delhi: Granting the clinical trial waiver, the Subject Expert Committee ( SEC) of the Central Drugs Standard Control Organization (CDSCO) has...
Biocon Biologics, Viatris launch cancer medicine Abevmy in Canada Ruchika Sharma20 May 2022 3:02 PM ISTAbevmy is a recombinant humanized monoclonal antibody that selectively binds to human vascular endothelial growth factor (VEGF) and neutralizes its...
Segmentectomy improves survival in small-sized peripheral non-small-cell lung cancer: Lancet Medical Dialogues Editorial Team7 May 2022 9:00 AM ISTJapan: A new study published in The Lancet shows that segmentectomy should be the usual surgical technique for individuals with early-stage...
Does Aspirin affect overall survival of patients with non-small cell lung cancer? MD Editorial Team20 Dec 2021 9:00 AM ISTStudies have shown that those who take aspirin have a lower risk of cancer and that aspirin has a chemopreventive effect in colorectal cancer....
Roche gets USFDA okay for cancer treatment Tecentriq Ruchika Sharma16 Oct 2021 4:30 PM ISTBasel: Roche has recently announced that the US Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) as adjuvant treatment,...
FDA approves first targeted oral therapy for very rare lung cancer Dr Kartikeya Kohli17 Sept 2021 9:39 AM ISTCAMBRIDGE, Mass - The U.S. Food and Drug Administration (FDA) has approved EXKIVITY (mobocertinib) for the treatment of adult patients with...
